Literature DB >> 13947380

[On the effects of I-DOPA on motor disorders in Parkinson's syndrome. An electromyographic study].

G GERSTENBRAND, K PATEISKY.   

Abstract

Entities:  

Keywords:  DOPA; ELECTROCARDIOGRAPHY; PARALYSIS AGITANS

Mesh:

Substances:

Year:  1962        PMID: 13947380

Source DB:  PubMed          Journal:  Wien Z Nervenheilkd Grenzgeb        ISSN: 0043-5384


× No keyword cloud information.
  7 in total

1.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

Review 2.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

3.  [Biochemical aspects of the effect of L-dopa in patients with Parkinson's disease].

Authors:  E Gründig; F Gerstenbrand; J Oberhummer; M Simanyi; R Schedl; J Weiss
Journal:  Z Neurol       Date:  1972

4.  [Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Authors:  W Birkmayer; M Mentasti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1967-08-08

5.  [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].

Authors:  E Gründig; F Gerstenbrand; J Bruck; H Gnad; P Prosenz; R Teuflmayr
Journal:  Dtsch Z Nervenheilkd       Date:  1969

6.  Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS.

Authors:  A M Ernst
Journal:  Psychopharmacologia       Date:  1965-05-21

Review 7.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.